← FDA DRUG APPROVALS

FDA ANDA · ANDA060006

PEN-VEE K

Sponsor: WYETH AYERST

APPLICATION
ANDA060006
TYPE
ANDA
ORIGINAL APPROVAL
1958-01-13
LATEST ACTION
1996-08-13
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PEN-VEE KDiscontinued
PENICILLIN V POTASSIUM EQ 250MG BASE · TABLET · ORAL
PEN-VEE KDiscontinued
PENICILLIN V POTASSIUM EQ 500MG BASE · TABLET · ORAL
PEN-VEE KDiscontinued
PENICILLIN V POTASSIUM EQ 125MG BASE · TABLET · ORAL

Approval history

1996-08-13Manufacturing (CMC) · Supplement 7AP
1992-03-11Labeling · Supplement 6AP
1958-01-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →